Fingolimod
RxNorm 1012892
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012892 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fingolimod.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Fingolimod
(Atom ID: 3307344)
PTPrescribable
Designated preferred name (PT):
Fingolimod
(Atom ID: 3800225)
FNPrescribable
Full form of descriptor (FN):
Fingolimod (substance)
(Atom ID: 3800226)
PTPrescribable
Designated preferred name (PT):
Fingolimod-containing product
(Atom ID: 10802977)
FNPrescribable
Full form of descriptor (FN):
Product containing fingolimod (medicinal product)
(Atom ID: 9257323)
Patient Education
Fingolimod
Fingolimod is used to prevent episodes of symptoms and slow the worsening of disability in adults and children 10 years of age and older with relapsing-remitting forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). Fingolimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.
[Learn More]
* Please review the disclaimer below.